These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 27830780)

  • 21. Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony.
    Forner S; Baglietto-Vargas D; Martini AC; Trujillo-Estrada L; LaFerla FM
    Trends Neurosci; 2017 Jun; 40(6):347-357. PubMed ID: 28494972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is amyloid-β harmful to the brain? Insights from human imaging studies.
    Jagust W
    Brain; 2016 Jan; 139(Pt 1):23-30. PubMed ID: 26614753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.
    Cohen ML; Kim C; Haldiman T; ElHag M; Mehndiratta P; Pichet T; Lissemore F; Shea M; Cohen Y; Chen W; Blevins J; Appleby BS; Surewicz K; Surewicz WK; Sajatovic M; Tatsuoka C; Zhang S; Mayo P; Butkiewicz M; Haines JL; Lerner AJ; Safar JG
    Brain; 2015 Apr; 138(Pt 4):1009-22. PubMed ID: 25688081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
    Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
    Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.
    Du F; Yu Q; Yan S; Hu G; Lue LF; Walker DG; Wu L; Yan SF; Tieu K; Yan SS
    Brain; 2017 Dec; 140(12):3233-3251. PubMed ID: 29077793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytoskeletal alterations in Alzheimer's disease: the "skeleton" of therapeutic hope?].
    Fodor KE; Pákáski M; Santha P; Janka Z; Kálmán J
    Neuropsychopharmacol Hung; 2011 Sep; 13(3):163-71. PubMed ID: 21876225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease.
    Yoon G; Shah SA; Ali T; Kim MO
    Mol Neurobiol; 2018 Aug; 55(8):6673-6686. PubMed ID: 29335844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.
    Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.
    Hock C; Konietzko U; Streffer JR; Tracy J; Signorell A; Müller-Tillmanns B; Lemke U; Henke K; Moritz E; Garcia E; Wollmer MA; Umbricht D; de Quervain DJ; Hofmann M; Maddalena A; Papassotiropoulos A; Nitsch RM
    Neuron; 2003 May; 38(4):547-54. PubMed ID: 12765607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.
    Hamel E; Royea J; Ongali B; Tong XK
    Cell Mol Neurobiol; 2016 Mar; 36(2):219-32. PubMed ID: 26993506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model.
    Kim JA; Ha S; Shin KY; Kim S; Lee KJ; Chong YH; Chang KA; Suh YH
    Cell Death Dis; 2015 Jun; 6(6):e1789. PubMed ID: 26086962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.